Refine by
Immunohistochemistry Articles & Analysis
24 news found
Additionally, Creative Diagnostics provides valuable data on viral disease progression, histology, immunohistochemistry, immunoassays, flow cytometry, cellular infiltration, cytokines, viral titers, LD50 studies, and vaccine/treatment efficacy. ...
It’s designed for use in various histological techniques such as immunohistochemistry (IHC) and in situ hybridization (ISH), and other routine procedures. ...
HER2 and FOLR1 testing by immunohistochemistry (IHC) is now available for all solid tumor cancers as an add-on to the company’s xT or xR next-generation sequencing assays. ...
ByTempus
By eliminating the need for additional immunohistochemistry, 4D Path’s cloud-based platform accelerates complete, actionable and objective insight leading to expedited and democratized precision medicine for optimized patient care and clinical trials. 4D Path’s cloud-based, quantitative approach provides clinical solutions in both companion diagnostics and ...
Meanwhile, each product is manufactured to high standards and fully validated in immunohistochemistry. Monoclonal and polyclonal antibodies from different hosts are also expertly designed to provide consistent specificity and sensitivity. ...
A biomarker strategy will include evaluation of a specific, sensitive and proprietary LILRB2 antibody for immunohistochemistry to enable tumor selection with an increased probability of success. ...
” Patients entering the trial are selected based on their expression of the KK-LC-1 antigen as determined by an immunohistochemistry assay. This assay was developed by T-Cure and validated for use in the ongoing trials. ...
The company has pioneered 3D Immunohistochemistry and developed many improvements to the CLARITY protocol, taking the protocol beyond the brain tissue it was originally intended for. ...
It has been adopted for various biochemical applications, such as western blotting, ELISA, and immunohistochemistry, and it is applied to amplify weak signaling and enhance the detection of target molecules, such as proteins. ...
With the effort of scientists at Profacgen, the company now provides soluble Fc fusion protein to applicate in various fields, including immunotherapy, non-clinical fields (flow cytometry, immunohistochemistry), in vitro activity detection and protein microarray detection with the deepening of research. ...
In certain cancer types, such as HER2-positive breast cancer, immunohistochemistry (IHC) analyses will also be performed to measure protein expression and reveal patients eligibility to anti-cancer drugs. ...
PGR is an estrogen-responsive gene and progesterone receptor (PR) expression, evaluated by immunohistochemistry (IHC), is used as a clinical biomarker of estrogen signaling and estrogen receptor (ER) functionality.1 Despite the well-studied role of PGR as mitogen and independent ER activator, anti-progestins for the treatment of BC have been poorly tested. ...
Key eligibility criteria: ECOG performance status of 0 or 1; HLA*02 positive with MAGE-A4 expression in ≥ 30% of tumor cells ≥ 2+ by immunohistochemistry; aged ≥ 16 and ≤ 75 years; and patients must have received either an anthracycline- or ifosfamide-containing regimen. ...
Long-term survival of the co-graft in the rat subretinal space and improvement in visual function were observed. Immunohistochemistry showed that the co-grafts grew, generated new photoreceptors and developed neuronal processes that were integrated into the host retinal. ...
As a result, the initial biopsy may no longer be the first step in a lengthy process towards biomarker profiling and stratification, but perhaps the only step necessary without the need for additional molecular tests (e.g., immunohistochemistry, FISH, NGS). Prior to his service to the Brazilian Ministry of Health, Teich founded and acted as president of GRUPO Clinical Oncology ...
Indeed, the initial histopathologist morphological diagnosis in the patient management pathway may no longer be the first step in a lengthy process towards biomarker profiling and stratification, but perhaps the only step, thus eliminating the need for additional expensive tests (e.g. immunohistochemistry, FISH, NGS). “The anxiety and distress associated with waiting for a ...
As a result, the initial biopsy will no longer be the first step in a lengthy process towards biomarker profiling and stratification, but perhaps the only step necessary without the need for additional molecular tests (e.g. immunohistochemistry, FISH, RNA-Seq, NGS). “I am excited about 4D Path’s novel way of providing molecular decision support and patient specific ...
As a result, the initial biopsy will no longer be the first step in a lengthy process towards biomarker profiling and stratification, but perhaps the only step necessary without the need for additional molecular tests (e.g. immunohistochemistry, FISH, RNA-Seq, NGS). Just from whole slide H&E biopsy/resection images, in seconds 4D Path can identify cancer, its pan-cancer ...
All together, these features position the Genexus System to enable a future in which local hospitals can adopt NGS testing in-house and sets the stage for molecular pathologists to eventually analyze NGS information in parallel with first-line testing modalities, such as immunohistochemistry (IHC). In May, Thermo Fisher announced the SARS-CoV-2 GlobalAccess program to accelerate ...
Anti-TdT, also a rabbit monoclonal antibody, is used to help classify lymphoma and leukemia by staining terminal deoxynucleotidyl transferase (TdT) in tissue samples. In immunohistochemistry, antibodies to TdT can be used to demonstrate the presence of pre-T and pre-B cells and multipotent hematopoietic stem cells that possess the antigen. ...